Fox News Flash top headlines are here. Check out what's clicking on Foxnews.com.
A chemotherapy drug could cause "significant" hearing loss among cancer survivors , according to a study from the University of South Florida and Indiana University. Researchers tracked 100 testicular cancer survivors who received a chemo drug called cisplatin for an average of 14 years, as a press release from USF noted. Among the participants, who averaged 48 years of age, 78% of them reported experiencing "significant difficulties in everyday listening situations.
" HALF OF CANCER DEATHS COULD HAVE BEEN PREVENTED THROUGH LIFESTYLE CHANGES, SAYS AMERICAN CANCER SOCIETY REPORT This was reportedly the first study to assess potential hearing loss among cancer survivors. "Patients receiving cisplatin-based chemotherapy are at high risk for permanent hearing loss, and for some, that hearing loss will progress years after chemo treatment," lead author Victoria Sanchez, associate professor in the USF Health Department of Otolaryngology Head & Neck Surgery, told Fox News Digital in an email. A chemotherapy drug could cause "significant" hearing loss among cancer survivors, according to a study.
(iStock) "This hearing loss affects how people hear in everyday life, like a noisy restaurant or other social gatherings." Cisplatin is a type of chemotherapy drug that contains the metal platinum, according to the National Cancer Institute’s website. ANCIENT EGYPTIANS ATTEMPTED TO SURGICALLY REMOVE BRAIN CANCE.